Floatz logo

Cyclophosphamide

Safety

Shanghai Jiao Tong University School of MedicineSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

31 Active assets in the Safety cohort.

Asset / SponsorPhaseRating
Bortezomib
Shandong Provincial Hospital
Phase 4BB
Gemtuzumab Ozogamicin
Pfizer
Phase 4BB
DEXAMETHASONE
Shandong Provincial Hospital
Phase 4B
Namenda
First Affiliated Hospital Xi'an Jiaotong University
Phase 4B
Famitinib
Anhui Provincial Hospital
Phase 3B

View all 48 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →